TAAS [28] is a measure assessing the acceptability of a treatment and a respondent’s anticipated adherence to that treatment. It is composed of ten questions, which respondents answer via a 7-point Likert scale. The items are summed with scores ranging from 10–70, with higher scores representing greater acceptability and anticipated adherence to the treatment in question [28]. The Cronbach’s alpha for TAAS was 0.86 in this study.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.